Corient Private Wealth
KURA icon

Corient Private Wealth’s Kura Oncology KURA Stock Holding History

Corient Private Wealth’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
122,709
+70,388
+135% +$664K ﹤0.01% 1629
2026
Q1 		$424K Buy
+52,321
New +$449K ﹤0.01% 2117
2025
Q3 		– Sell
-13,838
Closed -$79.8K – 2633
2025
Q2 		$79.8K Buy
13,838
+810
+6% +$4.96K ﹤0.01% 2355
2025
Q1 		$86K Buy
13,028
+538
+4% +$4.19K ﹤0.01% 2186
2024
Q4 		$109K Buy
+12,490
New +$180K ﹤0.01% 2212
2023
Q1 		– Sell
-38,500
Closed -$478K – 2037
2022
Q4 		$478K Buy
+38,500
New +$560K ﹤0.01% 1155

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Corient Private Wealth's KURA Position: Q2 2026 in Review

Corient Private Wealth increased its Kura Oncology (KURA) stake by 135% in Q2 2026, buying an estimated $664K and bringing the position to 122,709 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

Corient Private Wealth first reported a position in KURA in Q4 2022 and has held it in 6 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Corient Private Wealth held 122,709 shares of Kura Oncology worth $1.35M as of Q2 2026.
  • Corient Private Wealth bought 70,388 Kura Oncology shares in Q2 2026, an estimated $664K.
  • Kura Oncology made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1629 holding.
  • Corient Private Wealth first reported a position in Kura Oncology in Q4 2022 and has held it in 6 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.